ReleaseWire Connect

The IVIG products gained significant attention in the recent years due to their high efficacy in the treatment of immune diseases. Prevalence of various antibody deficiency disorders such as common variable immune deficiency (CVID), specific antibody deficiency, and hypogammaglobulinemia, increase in IVIG indications, improved production & purification processes, growth in awareness towards antibody deficiency, and rare immune disorders among patient population drive the growth of the Malaysia IVIG market. The scope of applications of IVIG has widened, as it is used to treat various neurological, hematological, dermatological, and immune deficiency disorders, with the help of improved clinical practices and advanced technologies.

Industrial Protective Footwear Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $$5,981 Million by 2022, registering a CAGR of 7.5% during the forecast period 2016-2022. The leather industrial protective footwear segment accounted for more than four-fifths of the total industrial protective footwear market revenue in 2015.

Vaccination administration employs antigenic components, which aid in strengthening an individuals immune system. This process assists in development of adaptive immunity to a pathogen, and thereby prevents morbidity from infection. Vaccination plays an important role in the prevention strategies of infectious diseases adopted by several countries. Demand for vaccines is high in countries susceptible to epidemic diseases, contributing to the significant market growth.

According to the new report published by Allied Market Research, titled, Axial Piston Hydraulic Motors and Pumps Market by Product and Application: Global Opportunity Analysis and Industry Forecast, 2014-2022, the axial piston hydraulic motors and pumps market was valued at $1,418 million in 2015, and is expected to reach at $ 1,882 million by 2022 during the forecast period. The axial piston hydraulic pumps segment is expected to dominate the global market. Asia-Pacific accounted for 34% of market share in 2014, and is expected to witness significant growth rate during the forecast period.

According to a new report published by Allied Market Research, titled, "Single-use Bioprocessing Market by Product, Application, Method, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global single-use bioprocessing market was valued at $2,800 million in 2016, and is projected to reach $9,342 million by 2023, growing at a CAGR of 18.7% from 2017 to 2023. The media bags & containers segment accounted for one-fourth share of the global market in 2016.

Europe Baby Monitor Market report, published by Allied Market Research, forecasts that the Europe market is expected to garner CAGR of 9% during the forecast period 2016 - 2022. France was the largest market, accounting for around 26% of the market value in 2015, owing to the large infant population and high spending on baby care in the country.

Organic chemicals would continue to be the highest revenue-generating segment during the forecast period. North America and Europe will continue to be the lead revenue generating economies through 2020. These regions collectively accounted for about three-fourth of share in the global pharmaceutical excipients market in 2015.

High prevalence and rising incidence rates of major types of cancers (such as breast cancer and prostate cancer), emerging treatment algorithms and widespread use of anti-cancer drugs for treating conditions such as blood cancer (leukemia) is expected to drive this market. In addition, growing popularity of biological and targeted drug therapies, which help in improving the patientssurvival time, are projected to provide opportunities in the LAMEA oncology/anti-cancer drugs market. However, factors such as high cost associated with cancer drugs and related side effects are likely to affect the market growth. Chemotherapy segment is expected to maintain a dominant share in the LAMEA oncology/cancer drugs market during the forecast period.

According to the new report published by Allied Market Research, titled, Elevator Modernization Market by Elevator Type, Components, End User, and Geography: Global Opportunity Analysis and Industry Forecast, 2014-2022, the global elevator modernization market is expected to reach $12,283 million by 2022. The traction segment is expected to dominate the market from 2016 to 2022. Asia-Pacific elevator modernization industry is expected to rise at the highest growth rate, whereas Europe accounted for around 37% share of the market in 2014, and is anticipated to grow at a significant rate.

The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.